MENU
RGNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

REGENXBIO (RGNX) Earnings Date & Reports

Regenxbio Inc is a biotechnology company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

RGNX is expected to report earnings to fall 9.42% to -125 cents per share on November 05

REGENXBIO RGNX Stock Earnings Reports
Q3'25
Est.
$-1.25
Q2'25
Missed
by $0.44
Q1'25
Missed
by $0.36
Q4'24
Beat
by $0.12
Q3'24
Missed
by $0.05
The last earnings report on August 07 showed earnings per share of -137 cents, missing the estimate of -93 cents. With 97.54K shares outstanding, the current market capitalization sits at 396.54M.
View a ticker or compare two or three
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RGNX showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of gene therapy treatments

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
344
Web
https://www.regenxbio.com